AlphaCentric Advisors LLC
- SEC CIK
- 0001913464
- Latest filing
- Jul 24, 2026
Holdings in Q4 2024
Holdings as of Dec 31, 2024, filed Jan 31, 2025. Long positions only; changes compare share counts with Q3 2024.
- Positions
- 209
- −21 vs. Q3 2024
- Portfolio value
- $100.2M
- −$34.3M (−25.5%) vs. Q3 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| NVONovo Nordisk A S | ADR | 23,334 | $2.01M | 2.0% | +23,334 | New | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 31,685 | $2.08M | 2.1% | +31,685 | New | History |
| TMOThermo Fisher Scientific Inc. | Stock | 4,175 | $2.17M | 2.2% | +4,175 | New | History |
| MRKMerck & Co., Inc. | Stock | 22,597 | $2.25M | 2.2% | −1,403−5.8% | Reduced | History |
| ABBVAbbVie Inc. | Stock | 13,018 | $2.31M | 2.3% | +13,018 | New | History |
| iShares Tr464287457 | 1 3 YR TREAS BD | 29,172 | $2.39M | 2.4% | +24,690+550.9% | Added | – |
| JNJJohnson & Johnson | Stock | 18,176 | $2.63M | 2.6% | +18,176 | New | History |
| UNHUnitedHealth Group Inc | Stock | 7,123 | $3.60M | 3.6% | +7,123 | New | History |
| LLYEli Lilly & Co | Stock | 6,140 | $4.74M | 4.7% | +6,140 | New | History |
Sold out since Q3 2024 (85)
Positions held at the end of Q3 2024 that are gone from this filing.
| Security | Class | Shares in Q3 2024 | Value in Q3 2024 | % of portfolio in Q3 2024 | History |
|---|---|---|---|---|---|
| RITMRithm Capital Corp. | REIT | 380,966 | $4.32M | 3.2% | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 97,000 | $3.88M | 2.9% | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 108,500 | $3.12M | 2.3% | History |
| EFCEllington Financial Inc. | COM | 201,602 | $2.60M | 1.9% | History |
| MTGMgic Investment Corp | COM | 99,379 | $2.54M | 1.9% | History |
| ARGXArgenx SE | SPONSORED ADR | 4,500 | $2.44M | 1.8% | History |
| INDVIndivior Pharmaceuticals, Inc. | ORD | 242,500 | $2.36M | 1.8% | History |
| DXDynex Capital Inc | COM | 181,492 | $2.32M | 1.7% | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 32,500 | $2.28M | 1.7% | History |
| DVAXDynavax Technologies Corp | COM NEW | 201,500 | $2.24M | 1.7% | History |
| UTHRUnited Therapeutics Corp | COM | 6,250 | $2.24M | 1.7% | History |
| RWTRedwood Trust Inc | COM | 288,343 | $2.23M | 1.7% | History |
| FOLDAmicus Therapeutics, Inc. | COM | 205,000 | $2.19M | 1.6% | History |
| MFAMfa Financial, Inc. | COM | 167,725 | $2.13M | 1.6% | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 370,000 | $2.06M | 1.5% | History |
| Invesco QQQ Trust Series I46090E103 | ETF | 4,182 | $2.04M | 1.5% | – |
| Invesco Nasdaq 100 ETF46138G649 | ETF | 10,158 | $2.04M | 1.5% | – |
| RPRXRoyalty Pharma plc | SHS CLASS A | 67,500 | $1.91M | 1.4% | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 45,000 | $1.75M | 1.3% | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 15,500 | $1.73M | 1.3% | History |
| MITTTPG Mortgage Investment Trust, Inc. | COM NEW | 208,879 | $1.57M | 1.2% | History |
| ACTEnact Holdings, Inc. | COM | 42,367 | $1.54M | 1.1% | History |
| ELSEquity Lifestyle Properties Inc | COM | 20,611 | $1.47M | 1.1% | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 20,000 | $1.46M | 1.1% | History |
| AMPHAmphastar Pharmaceuticals, Inc. | COM | 30,000 | $1.46M | 1.1% | History |
| GSKGSK plc | ADR | 35,000 | $1.43M | 1.1% | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 47,500 | $1.37M | 1.0% | History |
| ADAMAdamas Trust, Inc. | COM | 200,963 | $1.27M | 0.9% | History |
| RVNCRevance Therapeutics, Inc. | COM | 245,000 | $1.27M | 0.9% | History |
| ONCBeOne Medicines Ltd. | ADR | 5,500 | $1.23M | 0.9% | History |
| ENOVEnovis CORP | COM | 27,500 | $1.18M | 0.9% | History |
| Two HBRS Invt Corp90187BAB7 | NOTE 6.250% 1/1 | 1,205,000 | $1.18M | 0.9% | – |
| ROIVRoivant Sciences Ltd. | SHS | 100,000 | $1.15M | 0.9% | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 26,000 | $1.14M | 0.8% | History |
| TAKTakeda Pharmaceutical Co Ltd | ADR | 80,000 | $1.14M | 0.8% | History |
| CATXPerspective Therapeutics, Inc. | COM NEW | 80,000 | $1.07M | 0.8% | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 30,000 | $1.02M | 0.8% | History |
| SNYSanofi | SPONSORED ADR | 17,500 | $1.01M | 0.7% | History |
| IMVTImmunovant, Inc. | COM | 35,000 | $997.9K | 0.7% | History |
| LNTHLantheus Holdings, Inc. | Stock | 9,000 | $987.8K | 0.7% | History |
| Pennymac Corp70932AAD5 | NOTE 5.500%11/0 | 965,000 | $961.4K | 0.7% | – |
| AXSMAxsome Therapeutics, Inc. | COM | 10,500 | $943.6K | 0.7% | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 1,125,000 | $933.8K | 0.7% | History |
| AGNCAGNC Investment Corp. | REIT | 84,646 | $885.4K | 0.7% | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 37,500 | $848.6K | 0.6% | History |
| ONITOnity Group Inc. | COM NEW | 25,567 | $816.6K | 0.6% | History |
| PENPenumbra Inc | COM | 4,000 | $777.2K | 0.6% | History |
| VALNValneva SE | SPONSORED ADS | 118,000 | $717.4K | 0.5% | History |
| NUVLNuvalent, Inc. | COM | 7,000 | $716.1K | 0.5% | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 14,000 | $705.9K | 0.5% | History |
| CYTKCytokinetics Inc | COM NEW | 12,500 | $660.0K | 0.5% | History |
| ACADAcadia Pharmaceuticals Inc | COM | 40,000 | $615.2K | 0.5% | History |
| CGNXCognex Corp | COM | 15,000 | $607.5K | 0.5% | History |
| SGMTSagimet Biosciences Inc. | COM SER A | 185,000 | $512.5K | 0.4% | History |
| EMBCEmbecta Corp. | Stock | 36,000 | $507.6K | 0.4% | History |
| YARWYarrow Bioscience, Inc. | COM | 268,485 | $504.8K | 0.4% | History |
| KROSKeros Therapeutics, Inc. | COM | 8,000 | $464.6K | 0.3% | History |
| MDTMedtronic plc | Stock | 5,000 | $450.1K | 0.3% | History |
| DYNDyne Therapeutics, Inc. | COM | 10,000 | $359.2K | 0.3% | History |
| AVBPArriVent BioPharma, Inc. | COM | 15,000 | $352.5K | 0.3% | History |
| CHRSCoherus Oncology, Inc. | COM | 330,000 | $343.2K | 0.3% | History |
| VRDNViridian Therapeutics, Inc. | COM | 15,000 | $341.3K | 0.3% | History |
| VERAVera Therapeutics, Inc. | CL A | 7,500 | $331.5K | 0.2% | History |
| JSPRJasper Therapeutics, Inc. | COM NEW | 17,500 | $329.2K | 0.2% | History |
| SAFESafehold Inc. | COM | 11,972 | $314.0K | 0.2% | History |
| NUVBNuvation Bio Inc. | COM CL A | 135,000 | $309.1K | 0.2% | History |
| KNSAKiniksa Pharmaceuticals International, plc | ORD SHS CL A | 11,478 | $286.8K | 0.2% | History |
| IMTXImmatics N.V. | SHS | 25,000 | $285.3K | 0.2% | History |
| DXCMDexcom Inc | COM | 4,171 | $279.6K | 0.2% | History |
| VKTXViking Therapeutics, Inc. | COM | 3,500 | $221.6K | 0.2% | History |
| Vanguard Intl Equity Index F922042676 | GLB EX US ETF | 4,021 | $188.6K | 0.1% | – |
| TRMLTourmaline Bio, Inc. | COM | 5,500 | $141.4K | 0.1% | History |
| iShares Tr46429B408 | MSCI PHILIPS ETF | 4,517 | $131.6K | 0.1% | – |
| iShares Tr46429B309 | MSCI INDONIA ETF | 5,718 | $128.7K | 0.1% | – |
| PGNYProgyny, Inc. | COM | 7,500 | $125.7K | 0.1% | History |
| iShares Tr46429B606 | MSCI POLAND ETF | 5,067 | $122.8K | 0.1% | – |
| iShares Inc464286756 | MSCI SWEDEN ETF | 2,624 | $113.9K | 0.1% | – |
| iShares Inc464286707 | MSCI FRANCE ETF | 2,775 | $112.1K | 0.1% | – |
| iShares Inc464286814 | MSCI NETHERL ETF | 2,179 | $110.8K | 0.1% | – |
| iShares Inc464286749 | MSCI SWITZERLAND | 2,094 | $109.1K | 0.1% | – |
| STHOStar Holdings | SHS BEN INT | 7,744 | $107.2K | 0.1% | History |
| SPDR Series Trust78464A490 | ST STR FTSE ETF | 2,514 | $101.3K | 0.1% | – |
| iShares Inc464286772 | MSCI STH KOR ETF | 995 | $63.6K | <0.1% | – |
| iShares Inc464286640 | MSCI CHILE ETF | 1,556 | $42.4K | <0.1% | – |
| CGONCG Oncology, Inc. | COM | 1,000 | $37.7K | <0.1% | History |